A clever clinical trial tests a new drug sequence to outsmart one of oncology's toughest foes - pancreatic cancer.
Exploring the dual role of c-Jun transcription factor in pancreatic cancer survival and its therapeutic implications
Explore how the YY1 transcription factor regulates the DDX6/KIFC1 signaling axis in pancreatic cancer, driving tumor progression and therapeutic resistance.
Discover how the Qingyihuaji formula fights pancreatic cancer through the EphrinB1-EphB2 pathway and how EphB2 expression predicts treatment effectiveness.
Discover how a new small molecule compound targets Sp1 and Survivin to effectively inhibit pancreatic cancer cell proliferation.
Discover how gemcitabine chemotherapy may inadvertently strengthen pancreatic cancer stem-like cells through the induction of lncRNA HOTAIR, creating treatment resistance.
Discover how TRAIL-R1 regulates TGFβ signaling through microRNA-370-3p in pancreatic cancer cells, revealing new therapeutic targets.